进场进场!查看全文
慢慢赚钱2020-08-07 09:56
$德纳维制药(DVAX)$
二季报
1,乙肝疫苗收入240万美元,2019年2季度830万美元, 受疫情影响,预期内,
2,佐剂CpG 1018
2.1 COVID-19
2.1.1
与中国三叶草生物制药合作
scb-2019 一期,预期9月出结果
2.1.2
Medicago
一期,预期十月出结果
2.1.3
Me...查看全文
懂得做到2020-07-23 22:09
$德纳维制药(DVAX)$ 台湾medigen公司用了他家的CpG佐剂开发新冠疫苗,临床前数据不错,九月上一期。Dvax已经和四五家公司合作开发疫苗了,前景可期查看全文
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001104659-16-096141 Size: 70 KB 网页链接
$Dyax(DYAX)$ EFFECT - Notice of Effectiveness Filed: 2016-02-10 AccNo: 9999999995-16-003718 Size: 1 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-09 AccNo: 0001623632-16-002292 Size: 103 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-08 AccNo: 0001623632-16-002288 Size: 105 KB 网页链接
$Dyax(DYAX)$ CT ORDER - Confidential treatment order Filed: 2016-02-05 AccNo: 9999999997-16-016575 Size: 10 KB 网页链接
$Dyax(DYAX)$ 15-12G - Securities registration termination [Section 12(g)] Filed: 2016-02-01 AccNo: 0001104659-16-092917 Size: 23 KB 网页链接
$Dyax(DYAX)$ CT ORDER - Confidential treatment order Filed: 2016-02-01 AccNo: 9999999997-16-016468 Size: 10 KB 网页链接
$Dyax(DYAX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-01-26 AccNo: 0000215457-16-002509 Size: 13 KB 网页链接
$Dyax(DYAX)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-01-22 AccNo: 0001104659-16-091049 Size: 43 KB 网页链接
$Dyax(DYAX)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-01-22 AccNo: 0001104659-16-091048 Size: 43 KB 网页链接